Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?

Qin LuoQi JinZhihui ZhaoQing ZhaoXue YuLu YanYi ZhangChangming XiongZhihong Liu

Published in: BMC pulmonary medicine (2019)

Cautious use of targeted therapy could safely and effectively improve or stabilize hemodynamics and exercise capacity of some patients without any complications. PVOD patients could live longer than expected.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
physical activity
extracorporeal membrane oxygenation